Virtu Financial’s Citius Pharmaceuticals CTXR Stock Holding History

Virtu Financial’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Buy	+20,836	New	+$14.1K	﹤0.01%	1405
2024 Q4	–	Sell	-4,016	Closed	-$50K	–	1632
2024 Q3	$50K	Buy	+4,016	New	+$67.6K	﹤0.01%	1012
2024 Q1	–	Sell	-2,059	Closed	-$39K	–	1526
2023 Q4	$39K	Buy	+2,059	New	+$39K	﹤0.01%	1214
2023 Q3	–	Sell	-954	Closed	-$29K	–	1414
2023 Q2	$29K	Buy	+954	New	+$31.4K	﹤0.01%	1206
2023 Q1	–	Sell	-1,560	Closed	-$31K	–	1615
2022 Q4	$31K	Buy	+1,560	New	+$42.6K	﹤0.01%	1173
2022 Q3	–	Sell	-3,256	Closed	-$75K	–	1810
2022 Q2	$75K	Buy	+3,256	New	+$89.3K	0.01%	1007
2021 Q3	–	Sell	-789	Closed	-$69K	–	1588
2021 Q2	$69K	Buy	+789	New	+$47.4K	0.01%	1278
2021 Q1	–	Sell	-5,907	Closed	-$151K	–	1664
2020 Q4	$151K	Buy	5,907 +1,338	+29%	+$34.9K	0.02%	944
2020 Q3	$119K	Buy	4,569 +897	+24%	+$25.3K	0.02%	691
2020 Q2	$104K	Buy	+3,672	New	+$80.3K	0.01%	871
2019 Q4	–	Sell	-661	Closed	-$13K	–	1503
2019 Q3	$13K	Buy	+661	New	+$17.4K	﹤0.01%	1327

Other funds holding CTXR

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

AAG

Asset Advisory Group Kinnelon, New Jersey $229M AUM

Virtu Financial's CTXR Position: Q2 2026 in Review

Virtu Financial opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 20,836 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #1405 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CTXR as recently as Q3 2024.

Virtu Financial first reported a position in CTXR in Q3 2019 and has held it in 11 quarters since. The position peaked at $151K in Q4 2020. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

Virtu Financial held 20,836 shares of Citius Pharmaceuticals worth $13K as of Q2 2026.
Citius Pharmaceuticals was a new Virtu Financial position in Q2 2026.
Citius Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1405 holding.
Virtu Financial first reported a position in Citius Pharmaceuticals in Q3 2019 and has held it in 11 quarters since.
Virtu Financial's Citius Pharmaceuticals position peaked at $151K in Q4 2020.
43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.